{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["berberine", "bioavailability", "cancer", "cell signaling pathways", "synergistic effects"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36144625", "DateCompleted": {"Year": "2022", "Month": "09", "Day": "26"}, "DateRevised": {"Year": "2022", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "09", "Day": "10"}], "Language": ["eng"], "ELocationID": ["5889", "10.3390/molecules27185889"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "18", "PubDate": {"Year": "2022", "Month": "Sep", "Day": "10"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways.", "Abstract": {"AbstractText": ["Cancer is the most commonly diagnosed type of disease and a major cause of death worldwide. Despite advancement in various treatment modules, there has been little improvement in survival rates and side effects associated with this disease. Medicinal plants or their bioactive compounds have been extensively studied for their anticancer potential. Novel drugs based on natural products are urgently needed to manage cancer through attenuation of different cell signaling pathways. In this regard, berberine is a bioactive alkaloid that is found in variety of plants, and an inverse association has been revealed between its consumption and cancer. Berberine exhibits an anticancer role through scavenging free radicals, induction of apoptosis, cell cycle arrest, inhibition of angiogenesis, inflammation, PI3K/AKT/mammalian target of rapamycin (mTOR), Wnt/\u03b2-catenin, and the MAPK/ERK signaling pathway. In addition, synergistic effects of berberine with anticancer drugs or natural compounds have been proven in several cancers. This review outlines the anticancer effects and mechanisms of action of berberine in different cancers through modulation of various cell signaling pathways. Moreover, the recent developments in the drug delivery systems and synergistic effect of berberine are explained."]}, "AuthorList": [{"Identifier": ["0000-0002-5260-0265"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 52571, Saudi Arabia."}], "LastName": "Almatroodi", "ForeName": "Saleh A", "Initials": "SA"}, {"Identifier": ["0000-0001-9357-2216"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 52571, Saudi Arabia."}], "LastName": "Alsahli", "ForeName": "Mohammed A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 52571, Saudi Arabia."}], "LastName": "Rahmani", "ForeName": "Arshad Husain", "Initials": "AH"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "beta Catenin"}, {"RegistryNumber": "0I8Y3P32UF", "NameOfSubstance": "Berberine"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "TOR Serine-Threonine Kinases"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Berberine"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Biological Products"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phosphatidylinositol 3-Kinases"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "TOR Serine-Threonine Kinases"}, {"QualifierName": ["metabolism"], "DescriptorName": "beta Catenin"}], "CoiStatement": "The authors declare no conflict of interest for this work."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Pan-cancer analysis of whole genomes. Nature. 2020;578:82\u201393. doi: 10.1038/s41586-020-1969-6.", "ArticleIdList": ["10.1038/s41586-020-1969-6", "PMC7025898", "32025007"]}, {"Citation": "IARC . In: World Cancer Report, 2008. Boyle P., Levin B.E., editors. IARC Press; Lyon, France: 2008."}, {"Citation": "Anwar S., Almatroudi A., Alsahli M.A., Khan M.A., Khan A.A., Rahmani A.H. Natural Products: Implication in Cancer Prevention and Treatment through Modulating Various Biological Activities. Anticancer Agents Med. Chem. 2020;20:2025\u20132040. doi: 10.2174/1871520620666200705220307.", "ArticleIdList": ["10.2174/1871520620666200705220307", "32628596"]}, {"Citation": "Wu S., Zhu W., Thompson P., Hannun Y.A. Evaluating intrinsic and non-intrinsic cancer risk factors. Nat. Commun. 2018;9:3490. doi: 10.1038/s41467-018-05467-z.", "ArticleIdList": ["10.1038/s41467-018-05467-z", "PMC6113228", "30154431"]}, {"Citation": "Ames B.N. Mutagenesis and carcinogenesis: Endogenous and exogenous factors. Environ. Mol. Mutagen. 1989;14:66\u201377. doi: 10.1002/em.2850140614.", "ArticleIdList": ["10.1002/em.2850140614", "2659334"]}, {"Citation": "Hussain S., Harris C.C. Molecular epidemiology and carcinogenesis: Endogenous and exogenous carcinogens. Mutat. Res. Mutat. Res. 2000;462:311\u2013322. doi: 10.1016/S1383-5742(00)00015-6.", "ArticleIdList": ["10.1016/S1383-5742(00)00015-6", "10767641"]}, {"Citation": "Slattery M.L., Herrick J.S., Mullany L.E., Samowitz W.S., Sevens J.R., Sakoda L., Wolff R.K. The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer. Genes Chromosomes Cancer. 2017;56:769\u2013787. doi: 10.1002/gcc.22481.", "ArticleIdList": ["10.1002/gcc.22481", "PMC5597468", "28675510"]}, {"Citation": "Croce C.M., Reed J.C. Finally, an apoptosis-targeting therapeutic for cancer. Cancer Res. 2016;76:5914\u20135920. doi: 10.1158/0008-5472.CAN-16-1248.", "ArticleIdList": ["10.1158/0008-5472.CAN-16-1248", "PMC5117672", "27694602"]}, {"Citation": "Thomasset S.C., Berry D.P., Garcea G., Marczylo T., Steward W.P., Gescher A.J. Dietary polyphenolic phytochemicals\u2013promising cancer chemopreventive agents in humans? A review of their clinical properties. Int. J. Cancer. 2007;120:451\u2013458. doi: 10.1002/ijc.22419.", "ArticleIdList": ["10.1002/ijc.22419", "17131309"]}, {"Citation": "Bagherniya M., Khedmatgozar H., Fakheran O., Xu S., Johnston T.P., Sahebkar A. Medicinal plants and bioactive natural products as inhibitors of NLRP3 inflammasome. Phytother. Res. 2021;35:4804\u20134833. doi: 10.1002/ptr.7118.", "ArticleIdList": ["10.1002/ptr.7118", "33856730"]}, {"Citation": "Olcum M., Tastan B., Ercan I., Eltutan I.B., Genc S. Inhibitory effects of phytochemicals on NLRP3 inflammasome activation: A review. Phytomedicine. 2020;75:153238. doi: 10.1016/j.phymed.2020.153238.", "ArticleIdList": ["10.1016/j.phymed.2020.153238", "32507349"]}, {"Citation": "Zou K., Li Z., Zhang Y., Zhang H.-Y., Li B., Zhu W.-L., Shi J.-Y., Jia Q., Li Y.-M. Advances in the study of berberine and its derivatives: A focus on anti-inflammatory and anti-tumor effects in the digestive system. Acta Pharmacol. Sin. 2016;38:157\u2013167. doi: 10.1038/aps.2016.125.", "ArticleIdList": ["10.1038/aps.2016.125", "PMC5309756", "27917872"]}, {"Citation": "Tang J., Feng Y., Tsao S., Wang N., Curtain R., Wang Y. Berberine and Coptidis rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations. J. Ethnopharmacol. 2009;126:5\u201317. doi: 10.1016/j.jep.2009.08.009.", "ArticleIdList": ["10.1016/j.jep.2009.08.009", "19686830"]}, {"Citation": "Zhang X., Gu L., Li J., Shah N., He J., Yang L., Hu Q., Zhou M. Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells. Cancer Res. 2010;70:9895\u20139904. doi: 10.1158/0008-5472.CAN-10-1546.", "ArticleIdList": ["10.1158/0008-5472.CAN-10-1546", "PMC2999659", "20935220"]}, {"Citation": "Li J., Gu L., Zhang H., Liu T., Tian D., Zhou M., Zhou S. Berberine represses DAXX gene transcription and induces cancer cell apoptosis. Lab. Investig. 2013;93:354\u2013364. doi: 10.1038/labinvest.2012.172.", "ArticleIdList": ["10.1038/labinvest.2012.172", "PMC3961588", "23295648"]}, {"Citation": "Xiong R.G., Huang S.Y., Wu S.X., Zhou D.D., Yang Z.J., Saimaiti A., Zhao C.N., Shang A., Zhang Y.J., Gan R.Y., et al. Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review. Molecules. 2022;27:4523. doi: 10.3390/molecules27144523.", "ArticleIdList": ["10.3390/molecules27144523", "PMC9316001", "35889396"]}, {"Citation": "Rauf A., Abu-Izneid T., Khalil A.A., Imran M., Shah Z.A., Emran T.B., Mitra S., Khan Z., Alhumaydhi F.A., Aljohani A.S.M., et al. Berberine as a Potential Anticancer Agent: A Comprehensive Review. Molecules. 2021;26:7368. doi: 10.3390/molecules26237368.", "ArticleIdList": ["10.3390/molecules26237368", "PMC8658774", "34885950"]}, {"Citation": "Ray P.D., Huang B.W., Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012;24:981\u2013990. doi: 10.1016/j.cellsig.2012.01.008.", "ArticleIdList": ["10.1016/j.cellsig.2012.01.008", "PMC3454471", "22286106"]}, {"Citation": "Lu Q.B., Wan M.Y., Wang P.Y., Zhang C.X., Xu D.Y., Liao X., Sun H.J. Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFkappaB/mTOR/P70S6K signaling cascade. Redox Biol. 2018;14:656\u2013668. doi: 10.1016/j.redox.2017.11.012.", "ArticleIdList": ["10.1016/j.redox.2017.11.012", "PMC5716955", "29175753"]}, {"Citation": "Eissa L.A., Kenawy H.I., El-Karef A., Elsherbiny N.M., El-Mihi K.A. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats. Chem. Biol. Interact. 2018;294:91\u2013100. doi: 10.1016/j.cbi.2018.08.016.", "ArticleIdList": ["10.1016/j.cbi.2018.08.016", "30138605"]}, {"Citation": "Li Z., Jiang T., Lu Q., Xu K., He J., Xie L., Chen Z., Zheng Z., Ye L., Xu K., et al. Berberine attenuated the cytotoxicity induced by t-BHP via inhibiting oxidative stress and mitochondria dysfunction in PC-12 cells. Cell Mol. Neurobiol. 2020;40:587\u2013602. doi: 10.1007/s10571-019-00756-7.", "ArticleIdList": ["10.1007/s10571-019-00756-7", "31828466"]}, {"Citation": "Pongkittiphan V., Chavasiri W., Supabphol R. Antioxidant Effect of Berberine and its Phenolic Derivatives Against Human Fibrosarcoma Cells. Asian Pac. J. Cancer Prev. 2015;16:5371\u20135376. doi: 10.7314/APJCP.2015.16.13.5371.", "ArticleIdList": ["10.7314/APJCP.2015.16.13.5371", "26225680"]}, {"Citation": "Yahuafai J., Asai T., Oku N., Siripong P. Anticancer efficacy of the combination of berberine and PEGylated liposomal doxorubicin in meth A sarcoma-bearing mice. Biol. Pharm. Bull. 2018;41:1103\u20131106. doi: 10.1248/bpb.b17-00989.", "ArticleIdList": ["10.1248/bpb.b17-00989", "29962406"]}, {"Citation": "Hussain S.P., Harris C.C. Inflammation and cancer: An ancient link with novel potentials. Int. J. Cancer. 2007;121:2373\u20132380. doi: 10.1002/ijc.23173.", "ArticleIdList": ["10.1002/ijc.23173", "17893866"]}, {"Citation": "Colotta F., Allavena P., Sica A., Garlanda C., Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability. Carcinogenesis. 2009;30:1073\u20131081. doi: 10.1093/carcin/bgp127.", "ArticleIdList": ["10.1093/carcin/bgp127", "19468060"]}, {"Citation": "De Visser K.E., Eichten A., Coussens L.M. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer. 2006;6:24\u201337. doi: 10.1038/nrc1782.", "ArticleIdList": ["10.1038/nrc1782", "16397525"]}, {"Citation": "Hardbower D.M., Peek R.M., Jr., Wilson K.T. At the bench: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer. J. Leukoc. Biol. 2014;96:201\u2013212. doi: 10.1189/jlb.4BT0214-099R.", "ArticleIdList": ["10.1189/jlb.4BT0214-099R", "PMC4101087", "24868089"]}, {"Citation": "Grivennikov S.I., Karin M. Inflammation and oncogenesis: A vicious connection. Curr. Opin. Genet. Dev. 2020;20:65\u201371. doi: 10.1016/j.gde.2009.11.004.", "ArticleIdList": ["10.1016/j.gde.2009.11.004", "PMC2821983", "20036794"]}, {"Citation": "Dmitrieva O.S., Shilovskiy I.P., Khaitov M.R., Grivennikov S.I. Interleukins 1 and 6 as main mediators of inflammation and cancer. Biochemistry. 2016;81:80\u201390. doi: 10.1134/S0006297916020024.", "ArticleIdList": ["10.1134/S0006297916020024", "27260388"]}, {"Citation": "Almatroodi S.A., Alsahli M., Alharbi H.M., Khan A.A., Husain Rahmani A. Epigallocatechin-3-Gallate (EGCG), An Active Constituent of Green Tea: Implications in the Prevention of Liver Injury Induced by Diethylnitrosamine (DEN) in Rats. Appl. Sci. 2019;9:4821. doi: 10.3390/app9224821.", "ArticleIdList": ["10.3390/app9224821"]}, {"Citation": "Alzohairy M.A., Khan A.A., Alsahli M.A., Almatroodi S.A., Rahmani A.H. Protective Effects of Thymoquinone, an Active Compound of Nigella sativa, on Rats with Benzo(a)pyrene-Induced Lung Injury through Regulation of Oxidative Stress and Inflammation. Molecules. 2021;26:3218. doi: 10.3390/molecules26113218.", "ArticleIdList": ["10.3390/molecules26113218", "PMC8199466", "34072086"]}, {"Citation": "Zhao L., Zhang C. Berberine Inhibits MDA-MB-231 Cells by Attenuating Their Inflammatory Responses. Biomed Res Int. 2020;2020:3617514. doi: 10.1155/2020/3617514.", "ArticleIdList": ["10.1155/2020/3617514", "PMC7102481", "32258115"]}, {"Citation": "Yao M., Fan X., Yuan B., Takagi N., Liu S., Han X., Ren J., Liu J. Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell. BMC Complement Altern. Med. 2019;19:216. doi: 10.1186/s12906-019-2615-4.", "ArticleIdList": ["10.1186/s12906-019-2615-4", "PMC6694465", "31412862"]}, {"Citation": "Li H., Feng C., Fan C., Yang Y., Yang X., Lu H., Lu Q., Zhu F., Xiang C., Zhang Z., et al. Intervention of oncostatin M-driven mucosal inflammation by berberine exerts therapeutic property in chronic ulcerative colitis. Cell Death Dis. 2020;11:1\u201317. doi: 10.1038/s41419-020-2470-8.", "ArticleIdList": ["10.1038/s41419-020-2470-8", "PMC7181765", "32332711"]}, {"Citation": "Fuchs Y., Steller H. Programmed cell death in animal development and disease. Cell. 2011;147:742\u2013758. doi: 10.1016/j.cell.2011.10.033.", "ArticleIdList": ["10.1016/j.cell.2011.10.033", "PMC4511103", "22078876"]}, {"Citation": "Gross A., McDonnell J.M., Korsmeyer S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 1999;13:1899\u20131911. doi: 10.1101/gad.13.15.1899.", "ArticleIdList": ["10.1101/gad.13.15.1899", "10444588"]}, {"Citation": "Khan T., Ali M., Khan A., Nisar P., Jan S.A., Afridi S., Shinwari Z.K. Anticancer Plants: A Review of the Active Phytochemicals, Applications in Animal Models, and Regulatory Aspects. Biomolecules. 2019;10:47. doi: 10.3390/biom10010047.", "ArticleIdList": ["10.3390/biom10010047", "PMC7022400", "31892257"]}, {"Citation": "Wang N., Feng Y., Zhu M., Tsang C.M., Man K., Tong Y., Tsao S.W. Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: The cellular mechanism. J. Cell Biochem. 2010;111:1426\u20131436. doi: 10.1002/jcb.22869.", "ArticleIdList": ["10.1002/jcb.22869", "20830746"]}, {"Citation": "Zhao Y., Jing Z., Li Y., Mao W. Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis. Oncol. Rep. 2016;36:567\u2013572. doi: 10.3892/or.2016.4785.", "ArticleIdList": ["10.3892/or.2016.4785", "27177238"]}, {"Citation": "Wen C., Wu L., Fu L., Zhang X., Zhou H. Berberine enhances the anti-tumor activity of tamoxifen in drug-sensitive MCF-7 and drug-resistant MCF-7/TAM cells. Mol. Med. Rep. 2016;14:2250\u20132256. doi: 10.3892/mmr.2016.5490.", "ArticleIdList": ["10.3892/mmr.2016.5490", "27432642"]}, {"Citation": "Yip N.K., Yip N.K. Berberine induces apoptosis via the mitochondrial pathway in liver cancer cells. Oncol. Rep. 2013;30:1107\u20131112. doi: 10.3892/or.2013.2543.", "ArticleIdList": ["10.3892/or.2013.2543", "23784371"]}, {"Citation": "Wang K., Zhang C., Bao J., Jia X., Liang Y., Wang X., Chen M., Su H., Li P., Wan J.B., et al. Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death. Sci. Rep. 2016;6:26064. doi: 10.1038/srep26064.", "ArticleIdList": ["10.1038/srep26064", "PMC4893614", "27263652"]}, {"Citation": "Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132:27\u201342. doi: 10.1016/j.cell.2007.12.018.", "ArticleIdList": ["10.1016/j.cell.2007.12.018", "PMC2696814", "18191218"]}, {"Citation": "Colombo M.I. Autophagy: A pathogen driven process. IUBMB Life. 2007;59:238\u2013242. doi: 10.1080/15216540701230503.", "ArticleIdList": ["10.1080/15216540701230503", "17505959"]}, {"Citation": "Qu X., Zou Z., Sun Q., Luby-Phelps K., Cheng P., Hogan R.N., Gilpin C., Levine B. Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell. 2007;128:931\u2013946. doi: 10.1016/j.cell.2006.12.044.", "ArticleIdList": ["10.1016/j.cell.2006.12.044", "17350577"]}, {"Citation": "Liu J., Liu P., Xu T., Chen Z., Kong H., Chu W., Wang Y., Liu Y. Berberine Induces Autophagic Cell Death in Acute Lymphoblastic Leukemia by Inactivating AKT/mTORC1 Signaling. Drug Des. Dev. Ther. 2020;14:1813\u20131823. doi: 10.2147/DDDT.S239247.", "ArticleIdList": ["10.2147/DDDT.S239247", "PMC7229801", "32494123"]}, {"Citation": "Wang Y., Liu Y., Du X., Ma H., Yao J. Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer. Onco. Targets Ther. 2020;13:1909\u20131919. doi: 10.2147/OTT.S241632.", "ArticleIdList": ["10.2147/OTT.S241632", "PMC7061433", "32184626"]}, {"Citation": "Matera R., Saif M.W. New therapeutic directions for advanced pancreatic cancer: Cell cycle inhibitors, stromal modifiers and conjugated therapies. Expert Opin. Emerg. Drugs. 2017;22:223\u2013233. doi: 10.1080/14728214.2017.1362388.", "ArticleIdList": ["10.1080/14728214.2017.1362388", "28783977"]}, {"Citation": "Jahagirdar D., Gore C.R., Patel H., Maria K., Tandon I., Sharma N.K. Induction of apoptotic death and cell cycle arrest in HeLa cells by extracellular factors of breast cancer cells. Asian Pac. J. Cancer Prev. 2018;19:3307\u20133316. doi: 10.31557/APJCP.2018.19.12.3307.", "ArticleIdList": ["10.31557/APJCP.2018.19.12.3307", "PMC6428559", "30583335"]}, {"Citation": "Ruijtenberg S., van den Heuvel S. Coordinating cell proliferation and differentiation: Antagonism between cell cycle regulators and cell type-specific gene expression. Cell Cycle. 2016;15:196\u2013212. doi: 10.1080/15384101.2015.1120925.", "ArticleIdList": ["10.1080/15384101.2015.1120925", "PMC4825819", "26825227"]}, {"Citation": "Eo S.H., Kim J.H., Kim S.J. Induction of G\u2082/M Arrest by Berberine via Activation of PI3K/Akt and p38 in Human Chondrosarcoma Cell Line. Oncol. Res. 2014;22:147\u2013157. doi: 10.3727/096504015X14298122915583.", "ArticleIdList": ["10.3727/096504015X14298122915583", "PMC7838453", "26168133"]}, {"Citation": "Liu Z., Liu Q., Xu B., Wu J., Guo C., Zhu F., Yang Q., Gao G., Gong Y., Shao C. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage. Mutat. Res./Fundam. Mol. Mech. Mutagenesis. 2009;662:75\u201383. doi: 10.1016/j.mrfmmm.2008.12.009.", "ArticleIdList": ["10.1016/j.mrfmmm.2008.12.009", "19159633"]}, {"Citation": "Cai Y., Xia Q., Luo R., Huang P., Sun Y., Shi Y., Jiang W. Berberine inhibits the growth of human colorectal adenocarcinoma in vitro and in vivo. J. Nat. Med. 2014;68:53\u201362. doi: 10.1007/s11418-013-0766-z.", "ArticleIdList": ["10.1007/s11418-013-0766-z", "23604974"]}, {"Citation": "Sha S., Zhang Y., Xu B., Wang H., Kong X., Wu K. Effect of berberine on cell proliferation and apoptosis in gastric carcinoma cells. Mod. Oncol. 2011;19:629\u2013633."}, {"Citation": "Samad M.A., Saiman M.Z., Abdul Majid N., Karsani S.A., Yaacob J.S. Berberine Inhibits Telomerase Activity and Induces Cell Cycle Arrest and Telomere Erosion in Colorectal Cancer Cell Line, HCT 116. Molecules. 2021;26:376. doi: 10.3390/molecules26020376.", "ArticleIdList": ["10.3390/molecules26020376", "PMC7828342", "33450878"]}, {"Citation": "Hu H.-Y., Li K.-P., Wang X.-J., Liu Y., Lu Z.G., Dong R.H., Guo H.B., Zhang M.X. Set9, NF-\u03baB, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells. Acta Pharmacol. Sin. 2013;34:157\u2013166. doi: 10.1038/aps.2012.161.", "ArticleIdList": ["10.1038/aps.2012.161", "PMC4086496", "23247593"]}, {"Citation": "Yang Y., Sun M., Wang L., Jiao B. HIFs, angiogenesis, and cancer. J. Cell Biochem. 2013;114:967\u2013974. doi: 10.1002/jcb.24438.", "ArticleIdList": ["10.1002/jcb.24438", "23225225"]}, {"Citation": "Vandekeere S., Dewerchin M., Carmeliet P. Angiogenesis revisited: An overlooked role of endothelial cell metabolism in vessel sprouting. Microcirculation. 2015;22:509\u2013517. doi: 10.1111/micc.12229.", "ArticleIdList": ["10.1111/micc.12229", "26250801"]}, {"Citation": "Fakhri S., Abbaszadeh F., Jorjani M., Pourgholami M.H. The Effects of Anticancer Medicinal Herbs on Vascular Endothelial Growth Factor Based on Pharmacological Aspects: A Review Study. Nutr. Cancer. 2021;73:1\u201315. doi: 10.1080/01635581.2019.1673451.", "ArticleIdList": ["10.1080/01635581.2019.1673451", "31648565"]}, {"Citation": "Hamsa T.P., Kuttan G. Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators. Drug Chem. Toxicol. 2012;35:57\u201370. doi: 10.3109/01480545.2011.589437.", "ArticleIdList": ["10.3109/01480545.2011.589437", "22145808"]}, {"Citation": "Jie S., Li H., Tian Y., Guo D., Zhu J., Gao S., Jiang L. Berberine inhibits angiogenic potential of Hep G2 cell line through VEGF down-regulation in vitro. J. Gastroenterol. Hepatol. 2011;26:179\u2013185. doi: 10.1111/j.1440-1746.2010.06389.x.", "ArticleIdList": ["10.1111/j.1440-1746.2010.06389.x", "21175812"]}, {"Citation": "Kim S., Oh S.J., Lee J., Han J., Jeon M., Jung T., Lee S.K., Bae S.Y., Kim J., Gil W.H., et al. Berberine suppresses TPA-induced fibronectin expression through the inhibition of VEGF secretion in breast cancer cells. Cell Physiol. Biochem. 2013;32:1541\u20131550. doi: 10.1159/000356591.", "ArticleIdList": ["10.1159/000356591", "24335179"]}, {"Citation": "Katso R., Okkenhaug K., Ahmadi K., White S., Timms J., Waterfield M.D. Cellular function of phosphoinositide 3-kinases: Implications for development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 2001;17:615\u2013675. doi: 10.1146/annurev.cellbio.17.1.615.", "ArticleIdList": ["10.1146/annurev.cellbio.17.1.615", "11687500"]}, {"Citation": "Engelman J.A., Luo J., Cantley L.C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 2006;7:606\u2013619. doi: 10.1038/nrg1879.", "ArticleIdList": ["10.1038/nrg1879", "16847462"]}, {"Citation": "Martini M., de Santis M.C., Braccini L., Gulluni F., Hirsch E. PI3K/AKT signaling pathway and cancer: An updated review. Ann. Med. 2014;46:372\u2013383.", "ArticleIdList": ["24897931"]}, {"Citation": "Wang S., Yan Y., Cheng Z., Hu Y., Liu T. Sotetsuflavone Suppresses Invasion and Metastasis in Non-Small-Cell Lung Cancer A549 Cells by Reversing EMT via the TNF-\u03b1/NF-\u039aB and PI3K/AKT Signaling Pathway. Cell Death Discov. 2018;4:1\u201311.", "ArticleIdList": ["PMC5841291", "29531823"]}, {"Citation": "Chen L.M., Song T.J., Xiao J.H., Huang Z.H., Li Y., Lin T.Y. Tripchlorolide Induces Autophagy in Lung Cancer Cells by Inhibiting the PI3K/AKT/MTOR Pathway and Improves Cisplatin Sensitivity in A549/DDP Cells. Oncotarget. 2017;8:63911\u201363922.", "ArticleIdList": ["PMC5609972", "28969040"]}, {"Citation": "Liu F., Gao S., Yang Y., Zhao X., Fan Y., Ma W., Yang D., Yang A., Yu Y. Antitumor Activity of Curcumin by Modulation of Apoptosis and Autophagy in Human Lung Cancer A549 Cells through Inhibiting PI3K/Akt/MTOR Pathway. Oncol. Rep. 2018;39:1523\u20131531. doi: 10.3892/or.2018.6188.", "ArticleIdList": ["10.3892/or.2018.6188", "29328421"]}, {"Citation": "Li G., Zhang C., Liang W., Zhang Y., Shen Y., Tian X. Berberine regulates the Notch1/PTEN/PI3K/AKT/mTOR pathway and acts synergistically with 17-AAG and SAHA in SW480 colon cancer cells. Pharm. Biol. 2021;59:21\u201330. doi: 10.1080/13880209.2020.1865407.", "ArticleIdList": ["10.1080/13880209.2020.1865407", "PMC7808376", "33417512"]}, {"Citation": "Kou Y., Tong B., Wu W., Liao X., Zhao M. Berberine improves chemo-sensitivity to cisplatin by enhancing cell apoptosis and repressing PI3K/AKT/mTOR signaling pathway in gastric cancer. Front. Pharmacol. 2020;11:616251.", "ArticleIdList": ["PMC7756080", "33362566"]}, {"Citation": "Wang Y., Yuan J., Yang L., Wang P., Wang X., Wu Y., Chen K., Ma R., Zhong Y., Guo X., et al. Inhibition of migration and invasion by berberine via inactivation of PI3K/Akt and p38 in human retinoblastoma cell line. Adv. Clin. Exp. Med. 2018;27:899\u2013905. doi: 10.17219/acem/70418.", "ArticleIdList": ["10.17219/acem/70418", "29790698"]}, {"Citation": "Kipling D. The Telomere. Oxford University Press; Oxford, UK: 1995."}, {"Citation": "Blackburn E.H., Epel E.S., Lin J. Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection. Science. 2015;350:1193\u20131198. doi: 10.1126/science.aab3389.", "ArticleIdList": ["10.1126/science.aab3389", "26785477"]}, {"Citation": "Blackburn E.H. Telomeres and telomerase: The means to the end (Nobel lecture) Angew. Chem. Int. Ed. 2010;49:7405\u20137421. doi: 10.1002/anie.201002387.", "ArticleIdList": ["10.1002/anie.201002387", "20821774"]}, {"Citation": "Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011\u20132015. doi: 10.1126/science.7605428.", "ArticleIdList": ["10.1126/science.7605428", "7605428"]}, {"Citation": "Shay J.W., Bacchetti S. A survey of telomerase activity in human cancer. Eur. J. Cancer. 1997;33:787\u2013791. doi: 10.1016/S0959-8049(97)00062-2.", "ArticleIdList": ["10.1016/S0959-8049(97)00062-2", "9282118"]}, {"Citation": "Fu L., Chen W., Guo W., Wang J., Tian Y., Shi D., Zhang X., Qiu H., Xiao X., Kang T., et al. Berberine targets AP-2/hTERT, NF-\u03baB/COX-2, HIF-1\u03b1/VEGF and cytochrome-c/caspase signaling to suppress human cancer cell growth. PLoS ONE. 2013;8:e69240. doi: 10.1371/journal.pone.0069240.", "ArticleIdList": ["10.1371/journal.pone.0069240", "PMC3711861", "23869238"]}, {"Citation": "Salik B., Yi H., Hassan N., Santiappillai N., Vick B., Connerty P., Duly A., Trahair T., Woo A., Beck D., et al. Targeting RSPO3-LGR4 signaling for leukemia stem cell eradication in acute myeloid leukemia. Cancer Cell. 2020;38:263\u2013278. doi: 10.1016/j.ccell.2020.05.014.", "ArticleIdList": ["10.1016/j.ccell.2020.05.014", "32559496"]}, {"Citation": "Soleas J., D\u2019Arcangelo E., Huang L., Karoubi G., Nostro M., McGuigan A., Waddell T. Assembly of lung progenitors into developmentally-inspired geometry drives differentiation via cellular tension. Biomaterials. 2020;254:120128. doi: 10.1016/j.biomaterials.2020.120128.", "ArticleIdList": ["10.1016/j.biomaterials.2020.120128", "32474250"]}, {"Citation": "Choi B., Cave C., Na C., Sockanathan S. GDE2-dependent activation of canonical wnt signaling in neurons regulates oligodendrocyte maturation. Cell Rep. 2020;31:107540. doi: 10.1016/j.celrep.2020.107540.", "ArticleIdList": ["10.1016/j.celrep.2020.107540", "PMC7254694", "32375055"]}, {"Citation": "Albring K.F., Weidem\u00fcller J., Mittag S., Weiske J., Friedrich K., Geroni M.C., Lombardi P., Huber O. Berberine acts as a natural inhibitor of Wnt/\u03b2-catenin signaling--identification of more active 13-arylalkyl derivatives. Biofactors. 2013;39:652\u2013662. doi: 10.1002/biof.1133.", "ArticleIdList": ["10.1002/biof.1133", "23982892"]}, {"Citation": "Wu K., Yang Q., Mu Y., Zhou L., Liu Y., Zhou Q., He B. Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/\u03b2-catenin signaling. Int. J. Oncol. 2012;41:292\u2013298.", "ArticleIdList": ["22469784"]}, {"Citation": "Salomon D.S., Brandt R., Ciardiello F., Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol. 1995;19:183\u2013232. doi: 10.1016/1040-8428(94)00144-I.", "ArticleIdList": ["10.1016/1040-8428(94)00144-I", "7612182"]}, {"Citation": "Normanno N., Bianco C., de Luca A., Salomon D.S. The role of EGF related peptides in tumor growth. Front. Biosci. 2001;6:d685\u2013d707. doi: 10.2741/Normano.", "ArticleIdList": ["10.2741/Normano", "11333208"]}, {"Citation": "Wang L., Cao H., Lu N., Liu L., Wang B., Hu T., Israel D.A., Peek R.M., Jr., Polk D.B., Yan F. Berberine Inhibits Proliferation and Down-Regulates Epidermal Growth Factor Receptor through Activation of Cbl in Colon Tumor Cells. PLoS ONE. 2013;8:e56666. doi: 10.1371/journal.pone.0056666.", "ArticleIdList": ["10.1371/journal.pone.0056666", "PMC3573001", "23457600"]}, {"Citation": "Huang Z.H., Zheng H.F., Wang W.L., Wang Y., Zhong L.F., Wu J.L., Li Q.X. Berberine targets epidermal growth factor receptor signaling to suppress prostate cancer proliferation in vitro. Mol. Med. Rep. 2015;11:2125\u20132158. doi: 10.3892/mmr.2014.2929.", "ArticleIdList": ["10.3892/mmr.2014.2929", "25394789"]}, {"Citation": "Chinenov Y., Kerppola T.K. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene. 2001;20:2438\u20132452. doi: 10.1038/sj.onc.1204385.", "ArticleIdList": ["10.1038/sj.onc.1204385", "11402339"]}, {"Citation": "Vesely P.W., Staber P.B., Hoefler G., Kenner L. Translational regulation mechanisms of AP-1 proteins. Mutat Res. 2009;682:7\u201312. doi: 10.1016/j.mrrev.2009.01.001.", "ArticleIdList": ["10.1016/j.mrrev.2009.01.001", "19167516"]}, {"Citation": "Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1991;1072:129\u2013157.", "ArticleIdList": ["1751545"]}, {"Citation": "Kajanne R., Miettinen P., Tenhunen M., Leppa S. Transcription factor AP-1 promotes growth and radioresistance in prostate cancer cells. Int. J. Oncol. 2009;35:1175\u20131182.", "ArticleIdList": ["19787273"]}, {"Citation": "Eckert R.L., Adhikary G., Young C.A., Jans R., Crish J.F., Xu W., Rorke E.A. AP1 transcription factors in epidermal differentiation and skin cancer. J. Skin Cancer. 2013;2013:537028. doi: 10.1155/2013/537028.", "ArticleIdList": ["10.1155/2013/537028", "PMC3676924", "23762562"]}, {"Citation": "Mahata S., Bharti A.C., Shukla S., Tyagi A., Husain S.A., Das B.C. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol. Cancer. 2011;10:39. doi: 10.1186/1476-4598-10-39.", "ArticleIdList": ["10.1186/1476-4598-10-39", "PMC3098825", "21496227"]}, {"Citation": "Luo Y., Hao Y., Shi T.P., Dwng W.W., Li N. Berberine inhibits cyclin D1 expression via suppressed binding of AP-1 transcription factors to CCND1 AP-1 motif. Acta Pharmacol. Sin. 2008;29:628\u2013633. doi: 10.1111/j.1745-7254.2008.00786.x.", "ArticleIdList": ["10.1111/j.1745-7254.2008.00786.x", "18430372"]}, {"Citation": "Karin M. NF-kappaB as a critical link between inflammation and cancer. Cold Spring Harb. Perspect. Biol. 2009;1:a000141. doi: 10.1101/cshperspect.a000141.", "ArticleIdList": ["10.1101/cshperspect.a000141", "PMC2773649", "20066113"]}, {"Citation": "Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883\u2013899. doi: 10.1016/j.cell.2010.01.025.", "ArticleIdList": ["10.1016/j.cell.2010.01.025", "PMC2866629", "20303878"]}, {"Citation": "Grivennikov S.I., Karin M. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 2010;21:11\u201319. doi: 10.1016/j.cytogfr.2009.11.005.", "ArticleIdList": ["10.1016/j.cytogfr.2009.11.005", "PMC2834864", "20018552"]}, {"Citation": "Liu W., Zhang X., Liu P., Shen X., Lan T., Li W., Jiang Q., Xie X., Huang H. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury. Eur. J. Pharmacol. 2010;638:150\u2013155. doi: 10.1016/j.ejphar.2010.04.033.", "ArticleIdList": ["10.1016/j.ejphar.2010.04.033", "20447389"]}, {"Citation": "Yu M., Tong X., Qi B., Qu H., Dong S., Yu B., Zhang N., Tang N., Wang L., Zhang C. Berberine enhances chemosensitivity to irinotecan in colon cancer via inhibition of NF-\u03baB. Mol. Med. Rep. 2014;9:249\u2013254. doi: 10.3892/mmr.2013.1762.", "ArticleIdList": ["10.3892/mmr.2013.1762", "24173769"]}, {"Citation": "Karnam K.C., Ellutla M., Bodduluru L.N., Kasala E.R., Uppulapu S.K., Kalyankumarraju M., Lahkar M. Preventive effect of berberine against DMBA-induced breast cancer in female Sprague Dawley rats. Biomed. Pharmacother. 2017;92:207\u2013214. doi: 10.1016/j.biopha.2017.05.069.", "ArticleIdList": ["10.1016/j.biopha.2017.05.069", "28544934"]}, {"Citation": "Menegon S., Columbano A., Giordano S. The Dual Roles of NRF2 in Cancer. Trends Mol. Med. 2016;22:578\u2013593. doi: 10.1016/j.molmed.2016.05.002.", "ArticleIdList": ["10.1016/j.molmed.2016.05.002", "27263465"]}, {"Citation": "Xiang M., Namani A., Wu S., Wang X. Nrf2: Bane or blessing in cancer? J. Cancer Res. Clin. Oncol. 2014;140:1251\u20131259. doi: 10.1007/s00432-014-1627-1.", "ArticleIdList": ["10.1007/s00432-014-1627-1", "24599821"]}, {"Citation": "Bai X., Chen Y., Hou X., Huang M., Jin J. Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters. Drug Metab. Rev. 2016;48:541\u2013567. doi: 10.1080/03602532.2016.1197239.", "ArticleIdList": ["10.1080/03602532.2016.1197239", "27320238"]}, {"Citation": "You X., Cao X., Lin Y. Berberine enhances the radiosensitivity of hepatoma cells by Nrf2 pathway. Front. Biosci. 2019;24:1190\u20131202.", "ArticleIdList": ["31136975"]}, {"Citation": "Rawlings J.S., Rosler K.M., Harrison D.A. The JAK/STAT signaling pathway. J. Cell Sci. 2004;117:1281\u20131283. doi: 10.1242/jcs.00963.", "ArticleIdList": ["10.1242/jcs.00963", "15020666"]}, {"Citation": "Kim M., Morales L.D., Jang I.S., Cho Y.Y., Kim D.J. Protein tyrosine phosphatases as potential regulators of STAT3 signaling. Int. J. Mol. Sci. 2018;19:E2708. doi: 10.3390/ijms19092708.", "ArticleIdList": ["10.3390/ijms19092708", "PMC6164089", "30208623"]}, {"Citation": "Tsang C.M., Cheung Y.C., Lui V.W., Yip Y.L., Zhang G., Lin V.W., Cheung K.C., Feng Y., Tsao S.W. Berberine suppresses tumorigenicity and growth of nasopharyngeal carcinoma cells by inhibiting STAT3 activation induced by tumor associated fibroblasts. BMC Cancer. 2013;13:619. doi: 10.1186/1471-2407-13-619.", "ArticleIdList": ["10.1186/1471-2407-13-619", "PMC3890551", "24380387"]}, {"Citation": "Sun S., Zhang X., Xu M., Zhang F., Tian F., Cui J., Xia Y., Liang C., Zhou S., Wei H., et al. Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes. Cell Death Dis. 2019;10:274. doi: 10.1038/s41419-019-1510-8.", "ArticleIdList": ["10.1038/s41419-019-1510-8", "PMC6426889", "30894513"]}, {"Citation": "Jin G., Yang Y., Liu K., Zhao J., Chen X., Liu H., Bai R., Li X., Jiang Y., Zhang X. Combination curcumin and (\u2212)-epigallocatechin-3-gallate inhibits colorectal carcinoma microenvironment-induced angiogenesis by JAK/STAT3/IL-8 pathway. Oncogenesis. 2017;6:e384. doi: 10.1038/oncsis.2017.84.", "ArticleIdList": ["10.1038/oncsis.2017.84", "PMC5668882", "28967875"]}, {"Citation": "Zhou F., Hu J., Dai N., Song L., Lin T., Liu J., Li K., Peng Z., He Y., Liao D.F. Berberine and ginsenoside Rg3 act synergistically via the MAPK/ERK pathway in nasopharyngeal carcinoFma cells. J. Funct. Foods. 2020;66:103802. doi: 10.1016/j.jff.2020.103802.", "ArticleIdList": ["10.1016/j.jff.2020.103802"]}, {"Citation": "Kim H.S., Kim M.J., Kim E.J., Yang Y., Lee M.S., Lim J.S. Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. Biochem. Pharmacol. 2012;83:385\u2013394. doi: 10.1016/j.bcp.2011.11.008.", "ArticleIdList": ["10.1016/j.bcp.2011.11.008", "22120676"]}, {"Citation": "Zhang Q., Wang X., Cao S., Sun Y., He X., Jiang B., Yu Y., Duan J., Qiu F., Kang N. Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways. Biomed. Pharmacother. 2020;128:110245. doi: 10.1016/j.biopha.2020.110245.", "ArticleIdList": ["10.1016/j.biopha.2020.110245", "32454290"]}, {"Citation": "Liu C.H., Tang W.C., Sia P., Huang C.C., Yang P.M., Wu M.H., Lai I.L., Lee K.H. Berberine inhibits the metastatic ability of prostate cancer cells by suppressing epithelial-to-mesenchymal transition (EMT)-associated genes with predictive and prognostic relevance. Int. J. Med. Sci. 2015;12:63\u201371. doi: 10.7150/ijms.9982.", "ArticleIdList": ["10.7150/ijms.9982", "PMC4278877", "25552920"]}, {"Citation": "Li J., Cao B., Liu X., Fu X., Xiong Z., Chen L., Sartor O., Dong Y., Zhang H. Berberine suppresses androgen receptor signaling in prostate cancer. Molec. Cancer Ther. 2011;10:1346\u20131356. doi: 10.1158/1535-7163.MCT-10-0985.", "ArticleIdList": ["10.1158/1535-7163.MCT-10-0985", "PMC3154574", "21613449"]}, {"Citation": "Tian Y., Zhao L., Wang Y., Zhang H., Xu D., Zhao X., Li Y., Li J. Berberine inhibits androgen synthesis by interaction with aldo-keto reductase 1C3 in 22Rv1 prostate cancer cells. Asian J. Androl. 2016;18:607\u2013612.", "ArticleIdList": ["PMC4955188", "26698234"]}, {"Citation": "Zhang Q., Zhang C., Yang X., Yang B., Wang J., Kang Y., Wang Z., Li D., Huang G., Ma Z., et al. Berberine inhibits the expression of hypoxia induction factor-1alpha and increases the radiosensitivity of prostate cancer. Diagn. Pathol. 2014;9:98. doi: 10.1186/1746-1596-9-98.", "ArticleIdList": ["10.1186/1746-1596-9-98", "PMC4051149", "24886405"]}, {"Citation": "Lu W., Du S., Wang J. Berberine inhibits the proliferation of prostate cancer cells and induces G\u2080/G\u2081 or G\u2082/M phase arrest at different concentrations. Mol. Med. Rep. 2015;11:3920\u20133924. doi: 10.3892/mmr.2014.3139.", "ArticleIdList": ["10.3892/mmr.2014.3139", "25572870"]}, {"Citation": "Meeran S.M., Katiyar S., Katiyar S.K. Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. Toxicol. Appl. Pharmacol. 2008;229:33\u201343. doi: 10.1016/j.taap.2007.12.027.", "ArticleIdList": ["10.1016/j.taap.2007.12.027", "18275980"]}, {"Citation": "Li X., Zhang A., Sun H., Liu Z., Zhang T., Qiu S., Liu L., Wang X. Metabolic characterization and pathway analysis of berberine protects against prostate cancer. Oncotarget. 2017;8:65022. doi: 10.18632/oncotarget.17531.", "ArticleIdList": ["10.18632/oncotarget.17531", "PMC5630309", "29029409"]}, {"Citation": "Choi M.S., Oh J.H., Kim S.M., Jung H.Y., Yoo H.S., Lee Y.M., Moon D.C., Han S.B., Hong J.T. Berberine inhibits p53-dependent cell growth through induction of apopto-sis of prostate cancer cells. Int. J. Oncol. 2009;34:1221\u20131230. doi: 10.3892/ijo_00000250.", "ArticleIdList": ["10.3892/ijo_00000250", "19360335"]}, {"Citation": "Xia Y., Chen S., Cui J., Wang Y., Liu X., Shen Y., Gong L., Jiang X., Wang W., Zhu Y., et al. Berberine suppresses bladder cancer cell proliferation by inhibiting JAK1-STAT3 signaling via upregulation of miR-17-5p. Biochem. Pharmacol. 2021;188:114575. doi: 10.1016/j.bcp.2021.114575.", "ArticleIdList": ["10.1016/j.bcp.2021.114575", "33887260"]}, {"Citation": "Yan L., Yan K., Kun W., Xu L., Ma Q., Tang Y., Jiao W., Gu G., Fan Y., Xu Z. Berberine inhibits the migration and invasion of T24 bladder cancer cells via reducing the expression of heparanase. Tumour Biol. 2013;34:215\u2013221. doi: 10.1007/s13277-012-0531-z.", "ArticleIdList": ["10.1007/s13277-012-0531-z", "23065570"]}, {"Citation": "Yan K., Zhang C., Feng J., Hou L., Yan L., Zhou Z., Liu Z., Liu C., Fan Y., Zheng B., et al. Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells. Eur. J. Pharmacol. 2011;661:1\u20137. doi: 10.1016/j.ejphar.2011.04.021.", "ArticleIdList": ["10.1016/j.ejphar.2011.04.021", "21545798"]}, {"Citation": "Chung J.G., Wu L.T., Chu C.B., Jan J.Y., Ho C.C., Tsou M.F., Lu H.F., Chen G.W., Lin J.G., Wang T.F. Effects of berberine on arylamine N-acetyltransferase activity in human bladder tumour cells. Food Chem. Toxicol. 1999;37:319\u2013326. doi: 10.1016/S0278-6915(99)00016-2.", "ArticleIdList": ["10.1016/S0278-6915(99)00016-2", "10418949"]}, {"Citation": "Qin Q.P., Wang Z.F., Huang X.L., Tan M.X., Luo Z.H., Wang S.L., Zou B.Q., Liang H. Two telomerase-targeting Pt (II) complexes of jatrorrhizine and berberine derivatives induce apoptosis in human bladder tumor cells. Dalton Trans. 2019;48:15247\u201315254. doi: 10.1039/C9DT02381J.", "ArticleIdList": ["10.1039/C9DT02381J", "31577283"]}, {"Citation": "Gao X., Liu J., Fan D., Li X., Fang Z., Yan K., Fan Y. Berberine enhances gemcitabine-induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway. Oncol. Rep. 2022;47:1. doi: 10.3892/or.2021.8244.", "ArticleIdList": ["10.3892/or.2021.8244", "34935059"]}, {"Citation": "Lopes T.Z., de Moraes F.R., Tedesco A.C., Arni R.K., Rahal P., Calmon M.F. Berberine associated photodynamic therapy promotes autophagy and apoptosis via ROS generation in renal carcinoma cells. Biomed. Pharmacother. 2020;123:109794. doi: 10.1016/j.biopha.2019.109794.", "ArticleIdList": ["10.1016/j.biopha.2019.109794", "31874443"]}, {"Citation": "Lee S.J., Noh H.J., Sung E.G., Song I.H., Kim J.Y., Kwon T.K., Lee T.J. Berberine sensitizes TRAIL-induced apoptosis through proteasome-mediated downregulation of c-FLIP and Mcl-1 proteins. Int. J. Oncol. 2011;38:485\u2013492. doi: 10.3892/ijo.2010.878.", "ArticleIdList": ["10.3892/ijo.2010.878", "21170508"]}, {"Citation": "Och A., Podg\u00f3rski R., Nowak R. Biological activity of berberine\u2014A summary update. Toxins. 2020;12:713. doi: 10.3390/toxins12110713.", "ArticleIdList": ["10.3390/toxins12110713", "PMC7697704", "33198257"]}, {"Citation": "Zhang P., Wang Q., Lin Z., Yang P., Dou K., Zhang R. Berberine inhibits growth of liver cancer cells by suppressing glutamine uptake. Onco. Targets. Ther. 2019;12:11751. doi: 10.2147/OTT.S235667.", "ArticleIdList": ["10.2147/OTT.S235667", "PMC6978679", "32021249"]}, {"Citation": "Chuang T.-Y., Wu H.-L., Min J., Diamond M., Azziz R., Chen Y.-H. Berberine regulates the protein expression of multiple tumorigenesis-related genes in hepatocellular carcinoma cell lines. Cancer. Cell. Int. 2017;17:1\u20138. doi: 10.1186/s12935-017-0429-3.", "ArticleIdList": ["10.1186/s12935-017-0429-3", "PMC5450260", "28572744"]}, {"Citation": "Li F., Dong X., Lin P., Jiang J. Regulation of Akt/FoxO3a/Skp2 axis is critically involved in berberine-induced cell cycle arrest in hepatocellular carcinoma cells. Int. J. Mol. Sci. 2018;19:327. doi: 10.3390/ijms19020327.", "ArticleIdList": ["10.3390/ijms19020327", "PMC5855549", "29360760"]}, {"Citation": "Li J., Li O., Kan M., Zhang M., Shao D., Pan Y., Zheng H., Zhang X., Chen L., Liu S. Berberine induces apoptosis by suppressing the arachidonic acid metabolic pathway in hepatocellular carcinoma. Mol. Med. Rep. 2015;12:4572\u20134577. doi: 10.3892/mmr.2015.3926.", "ArticleIdList": ["10.3892/mmr.2015.3926", "26081696"]}, {"Citation": "Huang Y.Z., Wang K.Y., Gu C.X., Yu G.X., Zhao D., Mai W.J., Zhong Y., Liu S.M., Nie Y.Q., Yang H. Berberine, a natural plant alkaloid, synergistically sensitizes human liver cancer cells to sorafenib. Oncol. Rep. 2018;40:1525\u20131532. doi: 10.3892/or.2018.6552.", "ArticleIdList": ["10.3892/or.2018.6552", "30015938"]}, {"Citation": "Dai W., Mu L., Cui Y., Li Y., Chen P., Xie H., Wang X. Berberine promotes apoptosis of colorectal cancer via regulation of the long non-coding RNA (lncRNA) cancer susceptibility candidate 2 (CASC2)/AU-binding factor 1 (AUF1)/B-cell CLL/lymphoma 2 (Bcl-2) axis. Med. Sci. Monitor. 2019;25:730. doi: 10.12659/MSM.912082.", "ArticleIdList": ["10.12659/MSM.912082", "PMC6357823", "30681073"]}, {"Citation": "Liu H., Huang C., Wu L., Wen B. Effect of evodiamine and berberine on miR-429 as an oncogene in human colorectal cancer. Onco. Targets Ther. 2016;9:4121.", "ArticleIdList": ["PMC4940014", "27462166"]}, {"Citation": "L\u00fc Y., Han B., Yu H., Cui Z., Li Z., Wang J. Berberine regulates the microRNA-21-ITG\u03924-PDCD4 axis and inhibits colon cancer viability. Oncol. Lett. 2018;15:5971\u20135976.", "ArticleIdList": ["PMC5858122", "29564000"]}, {"Citation": "Liu X., Ji Q., Ye N., Sui H., Zhou L., Zhu H., Fan Z., Cai J., Li Q. Berberine inhibits invasion and metastasis of colorectal cancer cells via COX-2/PGE2 mediated JAK2/STAT3 signaling pathway. PLoS ONE. 2015;10:e0123478. doi: 10.1371/journal.pone.0123478.", "ArticleIdList": ["10.1371/journal.pone.0123478", "PMC4425560", "25954974"]}, {"Citation": "Gong C., Hu X., Xu Y., Yang J., Zong L., Wang C., Zhu J., Li Z., Lu D. Berberine inhibits proliferation and migration of colorectal cancer cells by downregulation of GRP78. Anti-Cancer Drugs. 2020;31:141\u2013149. doi: 10.1097/CAD.0000000000000835.", "ArticleIdList": ["10.1097/CAD.0000000000000835", "31743135"]}, {"Citation": "Ming M., Sinnett-Smith J., Wang J., Soares H.P., Young S.H., Eibl G., Rozengurt E. Dose-dependent AMPK-dependent and independent mechanisms of berberine and metformin inhibition of mTORC1, ERK, DNA synthesis and proliferation in pancreatic cancer cells. PLoS ONE. 2014;9:e114573.", "ArticleIdList": ["PMC4262417", "25493642"]}, {"Citation": "Park S.H., Sung J.H., Kim E.J., Chung N. Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines. Braz. J. Med. Biol. Res. 2014;48:111\u2013119. doi: 10.1590/1414-431x20144293.", "ArticleIdList": ["10.1590/1414-431x20144293", "PMC4321216", "25517919"]}, {"Citation": "Pinto-Garcia L., Efferth T., Torres A., Hoheisel J.D., Youns M. Berberine inhibits cell growth and mediates caspase-independent cell death in human pancreatic cancer cells. Planta Med. 2010;76:1155\u20131161. doi: 10.1055/s-0030-1249931.", "ArticleIdList": ["10.1055/s-0030-1249931", "20455200"]}, {"Citation": "Liu J., Luo X., Guo R., Jing W., Lu H. Cell Metabolomics Reveals Berberine-Inhibited Pancreatic Cancer Cell Viability and Metastasis by Regulating Citrate Metabolism. J. Proteome Res. 2020;19:3825\u20133836. doi: 10.1021/acs.jproteome.0c00394.", "ArticleIdList": ["10.1021/acs.jproteome.0c00394", "32692565"]}, {"Citation": "Abrams S.L., Follo M.Y., Steelman L.S., Lertpiriyapong K., Cocco L., Ratti S., Martelli A.M., Candido S., Libra M., Murata R.M., et al. Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells. Adv. Biol. Regul. 2019;71:172\u2013182. doi: 10.1016/j.jbior.2018.10.003.", "ArticleIdList": ["10.1016/j.jbior.2018.10.003", "30361003"]}, {"Citation": "Zhang C., Yang T., Chen X., Xu J., Liang D., Yi H., Chen S., Huang L., Liu N., Lin S. IE3S Web of Conferences Sciences. Volume 233. EDP Sciences; Les Ulis, France: 2021. A preliminary study on the synthetic lethal effect of berberine and olaparib on pancreatic cancer cells and its mechanism; p. 02023."}, {"Citation": "Lin J.P., Yang J.S., Wu C.C., Lin S.S., Hsieh W.T., Lin M.L., Yu F.S., Yu C.S., Chen G.W., Chang Y.H., et al. Berberine induced down-regulation of matrix metalloproteinase-1, -2 and -9 in human gastric cancer cells (SNU-5) in vitro. In Vivo. 2008;22:223\u2013230.", "ArticleIdList": ["18468407"]}, {"Citation": "Pandey A., Vishnoi K., Mahata S., Tripathi S.C., Misra S.P., Misra V., Mehrotra R., Dwivedi M., Bharti A.C. Berberine and Curcumin Target Survivin and STAT3 in Gastric Cancer Cells and Synergize Actions of Standard Chemotherapeutic 5-Fluorouracil. Nutr. Cancer. 2015;67:1293\u20131304. doi: 10.1080/01635581.2015.1085581.", "ArticleIdList": ["10.1080/01635581.2015.1085581", "26492225"]}, {"Citation": "Wang J., Yang S., Cai X., Dong J., Chen Z., Wang R., Zhang S., Cao H., Lu D., Jin T., et al. Berberine inhibits EGFR signaling and enhances the antitumor effects of EGFR inhibitors in gastric cancer. Oncotarget. 2016;7:76076\u201376086. doi: 10.18632/oncotarget.12589.", "ArticleIdList": ["10.18632/oncotarget.12589", "PMC5342797", "27738318"]}, {"Citation": "Hu Q., Li L., Zou X., Xu L., Yi P. Berberine attenuated proliferation, invasion and migration by targeting the AMPK/HNF4\u03b1/WNT5A pathway in gastric carcinoma. Front. Pharmacol. 2018;9:1150. doi: 10.3389/fphar.2018.01150.", "ArticleIdList": ["10.3389/fphar.2018.01150", "PMC6202939", "30405404"]}, {"Citation": "Wang M., Sun L.T., Wang L., Sun Y.N. Effects of berberine on circular RNA expression profiles in human gastric cancer cells. Evid. Based Complement. Altern. Med. 2021;2021:6688629. doi: 10.1155/2021/6688629.", "ArticleIdList": ["10.1155/2021/6688629", "PMC8112944", "34055022"]}, {"Citation": "Li H.L., Wu H., Zhang B.B., Shi H.L., Wu X.J. MAPK pathways are involved in the inhibitory effect of berberine hydrochloride on gastric cancer MGC 803 cell proliferation and IL-8 secretion in vitro and in vivo. Mol. Med. Rep. 2016;14:1430\u20131438. doi: 10.3892/mmr.2016.5361.", "ArticleIdList": ["10.3892/mmr.2016.5361", "27278862"]}, {"Citation": "Yi T., Zhuang L., Song G., Zhang B., Li G., Hu T. Akt signaling is associated with the berberine-induced apoptosis of human gastric cancer cells. Nutr. Cancer. 2015;67:523\u2013531. doi: 10.1080/01635581.2015.1004733.", "ArticleIdList": ["10.1080/01635581.2015.1004733", "25837881"]}, {"Citation": "Puthdee N., Seubwai W., Vaeteewoottacharn K., Boonmars T., Cha\u2019on U., Phoomak C., Wongkham S. Berberine Induces Cell Cycle Arrest in Cholangiocarcinoma Cell Lines via Inhibition of NF-\u03baB and STAT3 Pathways. Biol. Pharm. Bull. 2017;40:751\u2013757. doi: 10.1248/bpb.b16-00428.", "ArticleIdList": ["10.1248/bpb.b16-00428", "28566619"]}, {"Citation": "He W., Wang B., Zhuang Y., Shao D., Sun K., Chen J. Berberine inhibits growth and induces G1 arrest and apoptosis in human cholangiocarcinoma QBC939 cells. J. Pharmacol Sci. 2012;119:341\u2013348. doi: 10.1254/jphs.12052FP.", "ArticleIdList": ["10.1254/jphs.12052FP", "22850597"]}, {"Citation": "Cheng L., Xu P.H., Shen B.D., Shen G., Li J.J., Qiu L., Liu C.Y., Yuan H.L., Han J. Improve bile duct-targeted drug delivery and therapeutic efficacy for cholangiocarcinoma by cucurbitacin B loaded phospholipid complex modified with berberine hydrochloride. Int. J. Pharm. 2015;489:148\u2013157. doi: 10.1016/j.ijpharm.2015.04.024.", "ArticleIdList": ["10.1016/j.ijpharm.2015.04.024", "25882012"]}, {"Citation": "Jiang S.X., Qi B., Yao W.J., Gu C.W., Wei X.F., Zhao Y., Liu Y.Z., Zhao B.S. Berberine displays antitumor activity in esophageal cancer cells in vitro. World J. Gastroenterol. 2017;23:2511\u20132518. doi: 10.3748/wjg.v23.i14.2511.", "ArticleIdList": ["10.3748/wjg.v23.i14.2511", "PMC5394514", "28465635"]}, {"Citation": "Mishan M.A., Ahmadiankia N., Matin M.M., Heirani-Tabasi A., Shahriyari M., Bidkhori H.R., Naderi-Meshkin H., Bahrami A.R. Role of Berberine on molecular markers involved in migration of esophageal cancer cells. Cell Mol. Biol. 2015;61:37\u201343.", "ArticleIdList": ["26667771"]}, {"Citation": "Liu Q., Jiang H., Liu Z., Wang Y., Zhao M., Hao C., Feng S., Guo H., Xu B., Yang Q., et al. Berberine Radiosensitizes Human Esophageal Cancer Cells by Downregulating Homologous Recombination Repair Protein RAD51. PLoS ONE. 2011;6:e23427. doi: 10.1371/journal.pone.0023427.", "ArticleIdList": ["10.1371/journal.pone.0023427", "PMC3152570", "21858113"]}, {"Citation": "Ren K., Zhang W., Wu G., Ren J., Lu H., Li Z., Han X. Synergistic anti-cancer effects of galangin and berberine through apoptosis induction and proliferation inhibition in oesophageal carcinoma cells. Biomed. Pharmacother. 2016;84:1748\u20131759. doi: 10.1016/j.biopha.2016.10.111.", "ArticleIdList": ["10.1016/j.biopha.2016.10.111", "27876206"]}, {"Citation": "Iizuka N., Miyamoto K., Okita K., Tangoku A., Hayashi H., Yosino S., Abe T., Morioka T., Hazama S., Oka M. Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Lett. 2000;148:19\u201325. doi: 10.1016/S0304-3835(99)00264-5.", "ArticleIdList": ["10.1016/S0304-3835(99)00264-5", "10680588"]}, {"Citation": "Ni L., Li Z., Ren H., Kong L., Chen X., Xiong M., Zhang X., Ning B., Li J. Berberine inhibits non-small cell lung cancer cell growth through repressing DNA repair and replication rather than through apoptosis. Clin. Exp. Pharmacol. Physiol. 2022;49:134\u2013144. doi: 10.1111/1440-1681.13582.", "ArticleIdList": ["10.1111/1440-1681.13582", "34448246"]}, {"Citation": "Chen Q.Q., Shi J.M., Ding Z., Xia Q., Zheng T.S., Ren Y.B., Li M., Fan L.H. Berberine induces apoptosis in non-small-cell lung cancer cells by upregulating miR-19a targeting tissue factor. Cancer Manag Res. 2019;11:9005\u20139015. doi: 10.2147/CMAR.S207677.", "ArticleIdList": ["10.2147/CMAR.S207677", "PMC6814314", "31695492"]}, {"Citation": "Meng M., Geng S., Du Z., Yao J., Zheng Y., Li Z., Zhang Z., Li J., Duan Y., Du G. Berberine and cinnamaldehyde together prevent lung carcinogenesis. Oncotarget. 2017;8:76385\u201376397. doi: 10.18632/oncotarget.20059.", "ArticleIdList": ["10.18632/oncotarget.20059", "PMC5652713", "29100319"]}, {"Citation": "Zhu T., Li L.L., Xiao G.F., Luo Q.Z., Liu Q.Z., Yao K.T., Xiao G.H. Berberine Increases Doxorubicin Sensitivity by Suppressing STAT3 in Lung Cancer. Am. J. Chin. Med. 2015;43:1487\u20131502. doi: 10.1142/S0192415X15500846.", "ArticleIdList": ["10.1142/S0192415X15500846", "26503561"]}, {"Citation": "Li J., Liu F., Jiang S., Liu J., Chen X., Zhang S., Zhao H. Berberine hydrochloride inhibits cell proliferation and promotes apoptosis of non-small cell lung cancer via the suppression of the MMP2 and Bcl-2/Bax signaling pathways. Oncol. Lett. 2018;15:7409\u20137414. doi: 10.3892/ol.2018.8249.", "ArticleIdList": ["10.3892/ol.2018.8249", "PMC5920480", "29725453"]}, {"Citation": "Peng P.L., Kuo W.H., Tseng H.C., Chou F.P. Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: The contribution of autophagic cell death. Int. J. Radiat. Oncol. Biol. Phys. 2008;70:529\u2013542. doi: 10.1016/j.ijrobp.2007.08.034.", "ArticleIdList": ["10.1016/j.ijrobp.2007.08.034", "18207031"]}, {"Citation": "Peng P.L., Hsieh Y.S., Wang C.J., Hsu J.L., Chou F.P. Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicol. Appl. Pharmacol. 2006;214:8\u201315. doi: 10.1016/j.taap.2005.11.010.", "ArticleIdList": ["10.1016/j.taap.2005.11.010", "16387334"]}, {"Citation": "Lin C.C., Yang J.S., Chen J.T., Fan S., Yu F.S., Yang J.L., Lu C.C., Kao M.C., Huang A.C., Lu H.F., et al. Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway. Anticancer Res. 2007;27:3371\u20133378.", "ArticleIdList": ["17970083"]}, {"Citation": "Kuo C.L., Chi C.W., Liu T.Y. Modulation of apoptosis by berberine through inhibition of cyclooxygenase-2 and Mcl-1 expression in oral cancer cells. In Vivo. 2005;19:247\u2013252.", "ArticleIdList": ["15796182"]}, {"Citation": "Ho Y.T., Lu C.C., Yang J.S., Chiang J.H., Li T.C., Ip S.W., Hsia T.C., Liao C.L., Lin J.G., Wood W.G., et al. Berberine induced apoptosis via promoting the expression of caspase-8, -9 and -3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cells. Anticancer Res. 2009;29:4063\u20134070.", "ArticleIdList": ["19846952"]}, {"Citation": "Kim J.-S., Oh D., Yim M.-J., Park J.-J., Kang K.-R., Cho I.-A., Moon S.-M., Oh J.-S., You J.-S., Kim C.S. Berberine induces FasL-related apoptosis through p38 activation in KB human oral cancer cells. Oncol. Rep. 2015;33:1775\u20131782. doi: 10.3892/or.2015.3768.", "ArticleIdList": ["10.3892/or.2015.3768", "PMC4440222", "25634589"]}, {"Citation": "Wang H.Y., Yu H.Z., Huang S.M., Zheng Y.L. p53, Bcl-2 and cox-2 are involved in berberine hydrochloride-induced apoptosis of HeLa229 cells. Mol. Med. Rep. 2016;14:3855\u20133861. doi: 10.3892/mmr.2016.5696.", "ArticleIdList": ["10.3892/mmr.2016.5696", "27601129"]}, {"Citation": "Liu L., Sun L., Zheng J., Cui L. Berberine modulates Keratin 17 to inhibit cervical cancer cell viability and metastasis. J. Recept. Signal Transduct. 2021;41:521\u2013531. doi: 10.1080/10799893.2020.1830110.", "ArticleIdList": ["10.1080/10799893.2020.1830110", "33045871"]}, {"Citation": "Zeng X., Wan L., Wang Y., Xue J., Yang H., Zhu Y. Effect of low dose of berberine on the radioresistance of cervical cancer cells via a PI3K/HIF-1 pathway under nutrient-deprived conditions. Int. J. Radiat. Biol. 2020;96:1060\u20131067. doi: 10.1080/09553002.2020.1770358.", "ArticleIdList": ["10.1080/09553002.2020.1770358", "32412317"]}, {"Citation": "Lu B., Hu M., Liu K., Peng J. Cytotoxicity of berberine on human cervical carcinoma HeLa cells through mitochondria, death receptor and MAPK pathways, and in-silico drug-target prediction. Toxicol. In Vitro. 2010;24:1482\u20131490. doi: 10.1016/j.tiv.2010.07.017.", "ArticleIdList": ["10.1016/j.tiv.2010.07.017", "20656010"]}, {"Citation": "Chu S.C., Yu C.C., Hsu L.S., Chen K.S., Su M.Y., Chen P.N. Berberine reverses epithelial-to-mesenchymal transition and inhibits metastasis and tumor-induced angiogenesis in human cervical cancer cells. Mol. Pharmacol. 2014;86:609\u2013623. doi: 10.1124/mol.114.094037.", "ArticleIdList": ["10.1124/mol.114.094037", "25217495"]}, {"Citation": "Lin J.P., Yang J.S., Chang N.W., Chiu T.H., Su C.C., Lu K.W., Ho Y.T., Yeh C.C., Yang M.D., Lin H.J., et al. GADD153 mediates berberine-induced apoptosis in human cervical cancer Ca ski cells. Anticancer Res. 2007;27:3379\u20133386.", "ArticleIdList": ["17970084"]}, {"Citation": "Wang Y., Zhang S. Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2. Biomed. Pharmacother. 2018;103:1287\u20131293. doi: 10.1016/j.biopha.2018.04.161.", "ArticleIdList": ["10.1016/j.biopha.2018.04.161", "29864910"]}, {"Citation": "Mortazavi H., Nikfar B., Esmaeili S.A., Rafieenia F., Saburi E., Chaichian S., Gorji M.A., Momtazi-Borojeni A.A. Potential cytotoxic and anti-metastatic effects of berberine on gynaecological cancers with drug-associated resistance. Eur. J. Med. Chem. 2020;187:111951. doi: 10.1016/j.ejmech.2019.111951.", "ArticleIdList": ["10.1016/j.ejmech.2019.111951", "31821990"]}, {"Citation": "Gu Y., Zhou Z. Berberine inhibits the proliferation, invasion and migration of endometrial stromal cells by downregulating miR\u2212429. Mol. Med. Rep. 2021;23:416. doi: 10.3892/mmr.2021.12055.", "ArticleIdList": ["10.3892/mmr.2021.12055", "PMC8025458", "33846796"]}, {"Citation": "Jin P., Zhang C., Li N. Berberine exhibits antitumor effects in human ovarian cancer cells. Anticancer Agents Med Chem. 2015;15:511\u2013516. doi: 10.2174/1871520614666141226124110.", "ArticleIdList": ["10.2174/1871520614666141226124110", "25544381"]}, {"Citation": "Liu L., Fan J., Ai G., Liu J., Luo N., Li C., Cheng Z. Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells. Biol. Res. 2019;52:37. doi: 10.1186/s40659-019-0243-6.", "ArticleIdList": ["10.1186/s40659-019-0243-6", "PMC6637630", "31319879"]}, {"Citation": "Chen Q., Qin R., Fang Y., Li H. Berberine sensitizes human ovarian cancer cells to cisplatin through miR-93/PTEN/Akt signaling pathway. Cell. Physiol. Biochem. 2015;36:956\u2013965. doi: 10.1159/000430270.", "ArticleIdList": ["10.1159/000430270", "26087719"]}, {"Citation": "Chuang T.C., Wu K., Lin Y.Y., Kuo H.P., Kao M.C., Wang V., Hsu S.C., Lee S.L. Dual down-regulation of EGFR and ErbB2 by berberine contributes to suppression of migration and invasion of human ovarian cancer cells. Environ. Toxicol. 2021;36:737\u2013747. doi: 10.1002/tox.23076.", "ArticleIdList": ["10.1002/tox.23076", "33325633"]}, {"Citation": "Park K.S., Kim J.B., Lee S.J., Bae J. Berberine-induced growth inhibition of epithelial ovarian carcinoma cell lines. J. Obstet. Gynaecol. Res. 2012;38:535\u2013540. doi: 10.1111/j.1447-0756.2011.01743.x.", "ArticleIdList": ["10.1111/j.1447-0756.2011.01743.x", "22381105"]}, {"Citation": "Qian K., Tang C.Y., Chen L.Y., Zheng S., Zhao Y., Ma L.S., Xu L., Fan L.H., Yu J.D., Tan H.S., et al. Berberine Reverses Breast Cancer Multidrug Resistance Based on Fluorescence Pharmacokinetics In Vitro and In Vivo. ACS Omega. 2021;6:10645\u201310654. doi: 10.1021/acsomega.0c06288.", "ArticleIdList": ["10.1021/acsomega.0c06288", "PMC8153757", "34056218"]}, {"Citation": "Ponnusamy L., Kothandan G., Manoharan R. Berberine and Emodin abrogates breast cancer growth and facilitates apoptosis through inactivation of SIK3-induced mTOR and Akt signaling pathway. Biochim. Biophys. Acta Mol. Basis Dis. 2020;1866:165897. doi: 10.1016/j.bbadis.2020.165897.", "ArticleIdList": ["10.1016/j.bbadis.2020.165897", "32682817"]}, {"Citation": "Sakaguchi M., Kitaguchi D., Morinami S., Kurashiki Y., Hashida H., Miyata S., Yamaguchi M., Sakai M., Murata N., Tanaka S. Berberine-induced nucleolar stress response in a human breast cancer cell line. Biochem. Biophys. Res. Commun. 2020;528:227\u2013233. doi: 10.1016/j.bbrc.2020.05.020.", "ArticleIdList": ["10.1016/j.bbrc.2020.05.020", "32475643"]}, {"Citation": "Ma W., Zhang Y., Yu M., Wang B., Xu S., Zhang J., Li X., Ye X. In-vitro and in-vivo anti-breast cancer activity of synergistic effect of berberine and exercise through promoting the apoptosis and immunomodulatory effects. Int. Immunopharmacol. 2020;87:106787. doi: 10.1016/j.intimp.2020.106787.", "ArticleIdList": ["10.1016/j.intimp.2020.106787", "32707493"]}, {"Citation": "Kim J., Yu J.-H., Ko E., Lee K.-W., Song A., Park S., Shin I., Han W., Noh D. The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. Phytomedicine. 2010;17:436\u2013440. doi: 10.1016/j.phymed.2009.08.012.", "ArticleIdList": ["10.1016/j.phymed.2009.08.012", "19800775"]}, {"Citation": "Kim J.B., Lee K.M., Ko E., Han W., Lee J.E., Shin I., Bae J.Y., Kim S., Noh D.Y. Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231. Planta Med. 2008;74:39\u201342. doi: 10.1055/s-2007-993779.", "ArticleIdList": ["10.1055/s-2007-993779", "18203057"]}, {"Citation": "Pan Y., Zhang F., Zhao Y., Shao D., Zheng X., Chen Y., He K., Li J., Chen L. Berberine enhances chemosensitivity and induces apoptosis through dose-orchestrated AMPK signaling in breast cancer. J. Cancer. 2017;8:1679. doi: 10.7150/jca.19106.", "ArticleIdList": ["10.7150/jca.19106", "PMC5535724", "28775788"]}, {"Citation": "Park K.S., Kim J.B., Bae J., Park S.Y., Jee H.G., Lee K.E., Youn Y.K. Berberine inhibited the growth of thyroid cancer cell lines 8505C and TPC1. Yonsei Med. J. 2012;53:346\u2013351. doi: 10.3349/ymj.2012.53.2.346.", "ArticleIdList": ["10.3349/ymj.2012.53.2.346", "PMC3282951", "22318822"]}, {"Citation": "Li L., Wang X., Sharvan R., Gao J., Qu S. Berberine could inhibit thyroid carcinoma cells by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest and suppressing migration via PI3K-AKT and MAPK signaling pathways. Biomed. Pharmacother. 2017;95:1225\u20131231. doi: 10.1016/j.biopha.2017.09.010.", "ArticleIdList": ["10.1016/j.biopha.2017.09.010", "28931215"]}, {"Citation": "Kumarasamy V.M., Shin Y.J., White J., Sun D. Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine. BMC Cancer. 2015;15:599. doi: 10.1186/s12885-015-1610-5.", "ArticleIdList": ["10.1186/s12885-015-1610-5", "PMC4549123", "26307103"]}, {"Citation": "Scordino A., Campisi A., Grasso R., Bonfanti R., Gulino M., Iauk L., Parenti R., Musumeci F. Delayed luminescence to monitor programmed cell death induced by berberine on thyroid cancer cells. J. Biomed. Optics. 2014;19:117005. doi: 10.1117/1.JBO.19.11.117005.", "ArticleIdList": ["10.1117/1.JBO.19.11.117005", "25393968"]}, {"Citation": "Ren S., Cai Y., Hu S., Liu J., Zhao Y., Ding M., Chen X., Zhan L., Zhou X., Wang X. Berberine exerts anti-tumor activity in diffuse large B-cell lymphoma by modulating c-myc/CD47 axis. Biochem. Pharmacol. 2021;188:114576. doi: 10.1016/j.bcp.2021.114576.", "ArticleIdList": ["10.1016/j.bcp.2021.114576", "33930347"]}, {"Citation": "Goto H., Kariya R., Shimamoto M., Kudo E., Taura M., Katano H., Okada S. Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-\u03baB pathway. Cancer Sci. 2012;103:775\u2013781. doi: 10.1111/j.1349-7006.2012.02212.x.", "ArticleIdList": ["10.1111/j.1349-7006.2012.02212.x", "PMC7659260", "22320346"]}, {"Citation": "Wang D., Zhang K.F., Du G., Wang J., Zhao J. Berberine enhances the radiosensitivity of osteosarcoma by targeting Rad51 and epithelial-mesenchymal transition. J. Cancer Res. Ther. 2020;16:215\u2013221.", "ArticleIdList": ["32474504"]}, {"Citation": "Jin H., Jin X., Cao B., Wang W. Berberine affects osteosarcoma via downregulating the caspase-1/IL-1\u03b2 signaling axis. Oncol. Rep. 2017;37:729\u2013736. doi: 10.3892/or.2016.5327.", "ArticleIdList": ["10.3892/or.2016.5327", "PMC5355653", "28000894"]}, {"Citation": "Mishra R., Nathani S., Varshney R., Sircar D., Roy P. Berberine reverses epithelial-mesenchymal transition and modulates histone methylation in osteosarcoma cells. Mol. Biol. Rep. 2020;47:8499\u20138511. doi: 10.1007/s11033-020-05892-8.", "ArticleIdList": ["10.1007/s11033-020-05892-8", "33074411"]}, {"Citation": "Gao X., Zhang C., Wang Y., Zhang P., Zhang J., Hong T. Berberine and Cisplatin Exhibit Synergistic Anticancer Effects on Osteosarcoma MG-63 Cells by Inhibiting the MAPK Pathway. Molecules. 2021;26:1666. doi: 10.3390/molecules26061666.", "ArticleIdList": ["10.3390/molecules26061666", "PMC8002572", "33802664"]}, {"Citation": "Zhu Y., Ma N., Li H.X., Tian L., Ba Y.F., Hao B. Berberine induces apoptosis and DNA damage in MG-63 human osteosarcoma cells. Mol. Med. Rep. 2014;10:1734\u20131738. doi: 10.3892/mmr.2014.2405.", "ArticleIdList": ["10.3892/mmr.2014.2405", "PMC4148387", "25050485"]}, {"Citation": "Mohammadlou M., Abdollahi M., Hemati M., Baharlou R., Doulabi E.M., Pashaei M., Ghahremanfard F., Faranoush M., Kokhaei P. Apoptotic effect of berberine via Bcl-2, ROR1, and mir-21 in patients with B-chronic lymphocytic leukemia. Phytother. Res. PTR. 2021;35:2025\u20132033. doi: 10.1002/ptr.6945.", "ArticleIdList": ["10.1002/ptr.6945", "33174291"]}, {"Citation": "Ravera S., Ghiotto F., Tenca C., Gugiatti E., Santamaria S., Ledda B., Ibatici A., Cutrona G., Mazzarello A.N., Bagnara D., et al. Berberine affects mitochondrial activity and cell growth of leukemic cells from chronic lymphocytic leukemia patients. Sci. Rep. 2020;10:16519. doi: 10.1038/s41598-020-73594-z.", "ArticleIdList": ["10.1038/s41598-020-73594-z", "PMC7536443", "33020573"]}, {"Citation": "Liu J., Chen Z., Cui Y., Wei H., Zhu Z., Mao F., Wang Y., Liu Y. Berberine promotes XIAP-mediated cells apoptosis by upregulation of miR-24-3p in acute lymphoblastic leukemia. Aging. 2020;12:3298\u20133311. doi: 10.18632/aging.102813.", "ArticleIdList": ["10.18632/aging.102813", "PMC7066883", "32062612"]}, {"Citation": "Lin C.C., Lin S.Y., Chung J.G., Lin J.P., Chen G.W., Kao S.T. Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle. Anticancer Res. 2006;26:1097\u20131104.", "ArticleIdList": ["16619512"]}, {"Citation": "Wu H.L., Hsu C.Y., Liu W.H., Yung B.Y. Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity. Int. J. Cancer. 1999;81:923\u2013929. doi: 10.1002/(SICI)1097-0215(19990611)81:6<923::AID-IJC14>3.0.CO;2-D.", "ArticleIdList": ["10.1002/(SICI)1097-0215(19990611)81:6<923::AID-IJC14>3.0.CO;2-D", "10362140"]}, {"Citation": "Yu F.S., Yang J.S., Lin H.J., Yu C.S., Tan T.W., Lin Y.T., Lin C.C., Lu H.F., Chung J.G. Berberine inhibits WEHI-3 leukemia cells in vivo. In Vivo. 2007;21:407\u2013412.", "ArticleIdList": ["17436595"]}, {"Citation": "Kuo C.L., Chou C.C., Yung B.Y. Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells. Cancer Lett. 1995;93:193\u2013200. doi: 10.1016/0304-3835(95)03809-B.", "ArticleIdList": ["10.1016/0304-3835(95)03809-B", "7621428"]}, {"Citation": "Gu C., Yin Z., Nie H., Liu Y., Yang J., Huang G., Shen J., Chen L., Fei J. Identification of berberine as a novel drug for the treatment of multiple myeloma via targeting UHRF1. BMC Biol. 2020;18:33. doi: 10.1186/s12915-020-00766-8.", "ArticleIdList": ["10.1186/s12915-020-00766-8", "PMC7098108", "32213189"]}, {"Citation": "Tian Y., Li L.H., Yang G.Z., Chen W.M. [Study of the effects in vitro of berberine combined with bortezomib on multiple myeloma cell line U266 cells] Zhonghua Xue Ye Xue Za Zhi. 2016;37:976\u2013981.", "ArticleIdList": ["PMC7348517", "27995884"]}, {"Citation": "Luo X., Gu J., Zhu R., Feng M., Zhu X., Li Y., Fei J. Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine. BMC Syst. Biol. 2014;8:82. doi: 10.1186/1752-0509-8-82.", "ArticleIdList": ["10.1186/1752-0509-8-82", "PMC4096730", "25000828"]}, {"Citation": "Qing Y., Hu H., Liu Y., Feng T., Meng W., Jiang L., Sun Y., Yao Y. Berberine induces apoptosis in human multiple myeloma cell line U266 through hypomethylation of p53 promoter. Cell Biol. Int. 2014;38:563\u2013570. doi: 10.1002/cbin.10206.", "ArticleIdList": ["10.1002/cbin.10206", "24843889"]}, {"Citation": "Yin Z., Yang J., Ning R., Liu Y., Feng M., Gu C., Fei J., Li Y. Signal pathways, diseases, and functions associated with the miR-19a/92a cluster and the use of berberine to modulate the expression of this cluster in multiple myeloma cells. J. Biochem. Mol. Toxicol. 2018;32:e22057. doi: 10.1002/jbt.22057.", "ArticleIdList": ["10.1002/jbt.22057", "29687521"]}, {"Citation": "Jin F., Xie T., Huang X., Zhao X. Berberine inhibits angiogenesis in glioblastoma xenografts by targeting the VEGFR2/ERK pathway. Pharm. Biol. 2018;56:665\u2013671. doi: 10.1080/13880209.2018.1548627.", "ArticleIdList": ["10.1080/13880209.2018.1548627", "PMC6319470", "31070539"]}, {"Citation": "Palma T.V., Lenz L.S., Bottari N.B., Pereira A., Schetinger M.R.C., Morsch V.M., Ulrich H., Pillat M.M., de Andrade C.M. Berberine induces apoptosis in glioblastoma multiforme U87MG cells via oxidative stress and independent of AMPK activity. Mol. Biol. Rep. 2020;47:4393\u20134400. doi: 10.1007/s11033-020-05500-9.", "ArticleIdList": ["10.1007/s11033-020-05500-9", "32410137"]}, {"Citation": "Qu H., Song X., Song Z., Jiang X., Gao X., Bai L., Wu J., Na L., Yao Z. Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma. Cancer Cell Int. 2020;20:592. doi: 10.1186/s12935-020-01693-y.", "ArticleIdList": ["10.1186/s12935-020-01693-y", "PMC7727240", "33298057"]}, {"Citation": "Eom K.S., Kim H.J., So H.S., Park R., Kim T.Y. Berberine-induced apoptosis in human glioblastoma T98G cells is mediated by endoplasmic reticulum stress accompanying reactive oxygen species and mitochondrial dysfunction. Biol. Pharm. Bull. 2010;33:1644\u20131649. doi: 10.1248/bpb.33.1644.", "ArticleIdList": ["10.1248/bpb.33.1644", "20930370"]}, {"Citation": "Wang J., Qi Q., Feng Z., Zhang X., Huang B., Chen A., Prestegarden L., Li X., Wang J. Berberine induces autophagy in glioblastoma by targeting the AMPK/mTOR/ULK1-pathway. Oncotarget. 2016;7:66944. doi: 10.18632/oncotarget.11396.", "ArticleIdList": ["10.18632/oncotarget.11396", "PMC5341849", "27557493"]}, {"Citation": "Ren M., Yang L., Li D., Yang L., Su Y., Su X. Cell Cycle Regulation by Berberine in Human Melanoma A375 Cells. Bull. Exp. Biol. Med. 2020;169:491\u2013496. doi: 10.1007/s10517-020-04916-4.", "ArticleIdList": ["10.1007/s10517-020-04916-4", "32915362"]}, {"Citation": "Wang X., Gong Q., Song C., Fang J., Yang Y., Liang X., Huang X., Liu J. Berberine-photodynamic therapy sensitizes melanoma cells to cisplatin-induced apoptosis through ROS-mediated P38 MAPK pathways. Toxicol. Appl. Pharmacol. 2021;418:115484. doi: 10.1016/j.taap.2021.115484.", "ArticleIdList": ["10.1016/j.taap.2021.115484", "33716044"]}, {"Citation": "Serafim T.L., Oliveira P.J., Sardao V.A., Perkins E., Parke D., Holy J. Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line. Cancer Chemother. Pharmacol. 2008;61:1007\u20131018. doi: 10.1007/s00280-007-0558-9.", "ArticleIdList": ["10.1007/s00280-007-0558-9", "17661039"]}, {"Citation": "Singh T., Vaid M., Katiyar N., Sharma S., Katiyar S.K. RETRACTED: Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E2and prostaglandin E2receptors. Carcinogenesis. 2011;32:86\u201392. doi: 10.1093/carcin/bgq215.", "ArticleIdList": ["10.1093/carcin/bgq215", "PMC3924040", "20974686"]}, {"Citation": "Kou Y., Li L., Li H., Tan Y., Li B., Wang K., Du B. Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3K/AKT and RAR\u03b1/RAR\u03b2 in melanoma cells. Biochem. Biophys. Res. Commun. 2016;479:290\u2013296. doi: 10.1016/j.bbrc.2016.09.061.", "ArticleIdList": ["10.1016/j.bbrc.2016.09.061", "27639645"]}, {"Citation": "Wang X.N., Han X., Xu L.N., Yin L.H., Xu Y.W., Qi Y., Peng J.Y. Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine. Phytomedicine. 2008;15:1062\u20131068. doi: 10.1016/j.phymed.2008.05.002.", "ArticleIdList": ["10.1016/j.phymed.2008.05.002", "18579357"]}, {"Citation": "Zhang X.Z., Wang L., Liu D.W., Tang G.Y., Zhang H.Y. Synergistic inhibitory effect of berberine and d-limonene on human gastric carcinoma cell line MGC803. J. Med. Food. 2014;17:955\u2013962. doi: 10.1089/jmf.2013.2967.", "ArticleIdList": ["10.1089/jmf.2013.2967", "PMC4152785", "25045784"]}, {"Citation": "Balakrishna A., Kumar M.H. Evaluation of Synergetic Anticancer Activity of Berberine and Curcumin on Different Models of A549, Hep-G2, MCF-7, Jurkat, and K562 Cell Lines. Biomed. Res. Int. 2015;2015:354614. doi: 10.1155/2015/354614.", "ArticleIdList": ["10.1155/2015/354614", "PMC4499639", "26247019"]}, {"Citation": "Sengupta D., Chowdhury K.D., Chatterjee S., Sarkar A., Paul S., Sur P.K., Sadhukhan G.C. Modulation of adenylate cyclase signaling in association with MKK3/6 stabilization under combination of SAC and berberine to reduce HepG2 cell survivability. Apoptosis. 2017;22:1362\u20131379. doi: 10.1007/s10495-017-1407-x.", "ArticleIdList": ["10.1007/s10495-017-1407-x", "28836036"]}, {"Citation": "Tong N., Zhang J., Chen Y., Li Z., Luo Y., Zuo H., Zhao X. Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro. Oncol. Lett. 2012;3:1263\u20131267. doi: 10.3892/ol.2012.644.", "ArticleIdList": ["10.3892/ol.2012.644", "PMC3392583", "22783430"]}, {"Citation": "Zheng F., Li J., Ma C., Tang X., Tang Q., Wu J., Chai X., Xie J., Yang X.B., Hann S.S. Novel regulation of miR-34a-5p and HOTAIR by the combination of berberine and gefitinib leading to inhibition of EMT in human lung cancer. J. Cell. Mol. Med. 2020;24:5578\u20135592. doi: 10.1111/jcmm.15214.", "ArticleIdList": ["10.1111/jcmm.15214", "PMC7214156", "32248643"]}, {"Citation": "Mittal A., Tabasum S., Singh R.P. Berberine in combination with doxorubicin suppresses growth of murine melanoma B16F10 cells in culture and xenograft. Phytomedicine. 2014;21:340\u2013347. doi: 10.1016/j.phymed.2013.09.002.", "ArticleIdList": ["10.1016/j.phymed.2013.09.002", "24176840"]}, {"Citation": "You H.Y., Xie X.M., Zhang W.J., Zhu H.L., Jiang F.Z. Berberine modulates cisplatin sensitivity of human gastric cancer cells by upregulation of miR-203. In Vitro Cell Dev. Biol. Anim. 2016;52:857\u2013863. doi: 10.1007/s11626-016-0044-y.", "ArticleIdList": ["10.1007/s11626-016-0044-y", "27142767"]}, {"Citation": "Refaat A., Abdelhamed S., Yagita H., Inoue H., Yokoyama S., Hayakawa Y., Saiki I. Berberine Enhances Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated Apoptosis in Breast Cancer. Oncol. Lett. 2013;6:840\u2013844. doi: 10.3892/ol.2013.1434.", "ArticleIdList": ["10.3892/ol.2013.1434", "PMC3789109", "24137422"]}, {"Citation": "Youn M.J., So H.S., Cho H.J., Kim H.J., Kim Y., Lee J.H., Sohn J.S., Kim Y.K., Chung S.Y., Park R. Berberine, a natural product, combined with cisplatin enhanced apoptosis through a mitochondria/caspase-mediated pathway in HeLa cells. Biol. Pharm. Bull. 2008;31:789\u2013795. doi: 10.1248/bpb.31.789.", "ArticleIdList": ["10.1248/bpb.31.789", "18451495"]}, {"Citation": "Zhuo Y., Chen Q., Chen B., Zhan X., Qin X., Huang J., Lv X. Berberine promotes antiproliferative effects of epirubicin in T24 bladder cancer cells by enhancing apoptosis and cell cycle arrest. Int. J. Clin. Pharmacol. Ther. 2017;55:32\u201340. doi: 10.5414/CP202534.", "ArticleIdList": ["10.5414/CP202534", "27719740"]}, {"Citation": "Chen C.M., Chang H.C. Determination of berberine in plasma, urine and bile by high-performance liquid chromatography. J. Chromatogr. B Biomed. Appl. 1995;665:117\u2013123. doi: 10.1016/0378-4347(94)00517-9.", "ArticleIdList": ["10.1016/0378-4347(94)00517-9", "7795781"]}, {"Citation": "Tan X.S., Ma J.Y., Feng R., Ma C., Chen W.J., Sun Y.P., Fu J., Huang M., He C.Y., Shou J.W., et al. Tissue distribution of berberine and its metabolites after oral administration in rats. PLoS ONE. 2013;8:e77969.", "ArticleIdList": ["PMC3815028", "24205048"]}, {"Citation": "Spinozzi S., Colliva C., Camborata C., Roberti M., Ianni C., Neri F., Calvarese C., Lisotti A., Mazzella G., Roda A. Berberine and its metabolites: Relationship between physicochemical properties and plasma levels after administration to human subjects. J. Nat. Prod. 2014;77:766\u2013772. doi: 10.1021/np400607k.", "ArticleIdList": ["10.1021/np400607k", "24593257"]}, {"Citation": "Ma J.Y., Feng R., Tan X.S., Ma C., Shou J.W., Fu J., Huang M., He C.Y., Chen S.N., Zhao Z.X., et al. Excretion of berberine and its metabolites in oral administration in rats. J. Pharm. Sci. 2013;102:4181\u20134192. doi: 10.1002/jps.23718.", "ArticleIdList": ["10.1002/jps.23718", "24006193"]}, {"Citation": "Zuo F., Nakamura N., Akao T., Hattori M. Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry. Drug Metab. Dispos. 2006;34:2064\u20132072. doi: 10.1124/dmd.106.011361.", "ArticleIdList": ["10.1124/dmd.106.011361", "16956957"]}, {"Citation": "Mujtaba M.A., Akhter M.H., Alam M.S., Ali M.D., Hussain A. An Updated Review on Therapeutic Potential and Recent Advances in Drug Delivery of Berberine: Current Status and Future Prospect. Curr. Pharm. Biotechnol. 2022;23:60\u201371. doi: 10.2174/1389201022666210208152113.", "ArticleIdList": ["10.2174/1389201022666210208152113", "33557735"]}, {"Citation": "Almatroodi S.A., Syed M.A., Rahmani A.H. Potential Therapeutic Targets of Curcumin, Most Abundant Active Compound of Turmeric Spice: Role in the Management of Various Types of Cancer. Recent Pat. Anticancer Drug Discov. 2021;16:3\u201329. doi: 10.2174/1574892815999201102214602.", "ArticleIdList": ["10.2174/1574892815999201102214602", "33143616"]}, {"Citation": "Almatroudi S.A., Alsahli M.A., Alrumaihi F., Allemailem K.S., Rahmani A.H. Ginger: A Novel Strategy to Battle Cancer through Modulating Cell Signalling Pathways: A Review. Curr. Pharm. Biotechnol. 2019;20:5\u201316. doi: 10.2174/1389201020666190119142331.", "ArticleIdList": ["10.2174/1389201020666190119142331", "30659535"]}, {"Citation": "Almatroodi S.A., Alsahli M.A., Almatroudi A., Rahmani A.H. Garlic and its Active Compounds: A Potential Candidate in The Prevention of Cancer by Modulating Various Cell Signalling Pathways. Anticancer Agents Med. Chem. 2019;19:1314\u20131324. doi: 10.2174/1871520619666190409100955.", "ArticleIdList": ["10.2174/1871520619666190409100955", "30963982"]}, {"Citation": "Almatroodi S.A., Alsahli M.A., Almatroudi A., Anwar S., Verma A.K., Dev K., Rahmani A.H. Cinnamon and its active compounds: A potential candidate in disease and tumour management through modulating various genes activity. Gene Rep. 2020;21:100966. doi: 10.1016/j.genrep.2020.100966.", "ArticleIdList": ["10.1016/j.genrep.2020.100966"]}, {"Citation": "Almatroodi S.A., Alsahli M., Aljohani S.M.A., Alhumaydhi F.A., Babiker A.Y., Khan A.A., Rahmani A.H. Potential Therapeutic Targets of Resveratrol, a Plant Polyphenol, and Its Role in the Therapy of Various Types of Cancer. Molecules. 2022;27:2665. doi: 10.3390/molecules27092665.", "ArticleIdList": ["10.3390/molecules27092665", "PMC9101422", "35566016"]}, {"Citation": "Almatroodi S.A., Ahmad A., Amjad A., Khan A.A., Fahad A., Alhumaydhi M.A., Rahmani A.H. Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer. Molecules. 2020;25:3146. doi: 10.3390/molecules25143146.", "ArticleIdList": ["10.3390/molecules25143146", "PMC7397003", "32660101"]}, {"Citation": "Mostafavi E., Soltantabar P., Webster T.J. Nanotechnology and picotechnology: A new arena for translational medicine. Biomater. Trans. Med. 2019;2019:191\u2013212."}, {"Citation": "Sahibzada M.U.K., Sadiq A., Faidah H.S., Khurram M., Amin M.U., Haseeb A., Kakar M. Berberine nanoparticles with enhanced in vitro bioavailability: Characterization and antimicrobial activity. Drug Des. Devel. Ther. 2018;12:303\u2013312. doi: 10.2147/DDDT.S156123.", "ArticleIdList": ["10.2147/DDDT.S156123", "PMC5817421", "29491706"]}, {"Citation": "Loo Y.S., Madheswaran T., Rajendran R., Bose R.J. Encapsulation of berberine into liquid crystalline nanoparticles to enhance its solubility and anticancer activity in MCF7 human breast cancer cells. J. Drug Deliv. Sci. Technol. 2020;57:101756. doi: 10.1016/j.jddst.2020.101756.", "ArticleIdList": ["10.1016/j.jddst.2020.101756"]}, {"Citation": "Wang Y., Wen B., Yu H., Ding D., Zhang J., Zhang Y., Zhao L., Zhang W. Berberine Hydrochloride-Loaded Chitosan Nanoparticles Effectively Targets and Suppresses Human Nasopharyngeal Carcinoma. J. Biomed. Nanotechnol. 2018;14:1486\u20131495. doi: 10.1166/jbn.2018.2596.", "ArticleIdList": ["10.1166/jbn.2018.2596", "29903063"]}, {"Citation": "Li X.D., Wang Z., Wang X.R., Shao D., Zhang X., Li L., Ge M.F., Chang Z.M., Dong W.F. Berberine-loaded Janus gold mesoporous silica nanocarriers for chemo/radio/photothermal therapy of liver cancer and radiation-induced injury inhibition. Int. J. Nanomed. 2019;14:3967\u20133982. doi: 10.2147/IJN.S206044.", "ArticleIdList": ["10.2147/IJN.S206044", "PMC6554520", "31239666"]}, {"Citation": "Bhanumathi R., Vimala K., Shanthi K., Thangaraj R., Kannan S. Bioformulation of silver nanoparticles as berberine carrier cum anticancer agent against breast cancer. N. J. Chem. 2017;41:14466\u201314477. doi: 10.1039/C7NJ02531A.", "ArticleIdList": ["10.1039/C7NJ02531A"]}, {"Citation": "Bhanumathi R., Manivannan M., Thangaraj R., Kannan S. Drug-Carrying Capacity and Anticancer Effect of the Folic Acid- and Berberine-Loaded Silver Nanomaterial to Regulate the AKT-ERK Pathway in Breast Cancer. ACS Omega. 2018;3:8317\u20138328. doi: 10.1021/acsomega.7b01347.", "ArticleIdList": ["10.1021/acsomega.7b01347", "PMC6072244", "30087941"]}, {"Citation": "Dziedzic A., Kubina R., Bu\u0142dak R.J., Skonieczna M., Cholewa K. Silver Nanoparticles Exhibit the Dose-Dependent Anti-Proliferative Effect against Human Squamous Carcinoma Cells Attenuated in the Presence of Berberine. Molecules. 2016;21:365. doi: 10.3390/molecules21030365.", "ArticleIdList": ["10.3390/molecules21030365", "PMC6274313", "26999092"]}, {"Citation": "Wang L., Li H., Wang S., Liu R., Wu Z., Wang C., Wang Y., Chen M. Enhancing the antitumor activity of berberine hydrochloride by solid lipid nanoparticle encapsulation. AAPS Pharm. Sci. Tech. 2014;15:834\u2013844. doi: 10.1208/s12249-014-0112-0.", "ArticleIdList": ["10.1208/s12249-014-0112-0", "PMC4113611", "24696391"]}, {"Citation": "Parhi P., Suklabaidya S., Kumar Sahoo S. Enhanced anti-metastatic and anti-tumorigenic efficacy of Berbamine loaded lipid nanoparticles in vivo. Sci. Rep. 2017;7:5806. doi: 10.1038/s41598-017-05296-y.", "ArticleIdList": ["10.1038/s41598-017-05296-y", "PMC5517447", "28724926"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "10"}, {"Year": "2022", "Month": "8", "Day": "31"}, {"Year": "2022", "Month": "9", "Day": "6"}, {"Year": "2022", "Month": "9", "Day": "23", "Hour": "1", "Minute": "36"}, {"Year": "2022", "Month": "9", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "10"}], "PublicationStatus": "epublish", "ArticleIdList": ["36144625", "PMC9505063", "10.3390/molecules27185889", "molecules27185889"]}}], "PubmedBookArticle": []}